NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 12, 2025
- Amount
- $475,000
- Closes
- Aug 17, 2026 (in 6 days)
Similar opportunities open now
- NIH Director’s Pioneer Award (DP1 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 29 daysUp to $700K
- NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 30 daysUp to $350K
- NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 23 days
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses May 2029
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)OpenNational Institutes of HealthCloses Apr 2027
Classification and identifiers
- Solicitation number
- RFA-RM-27-002
- Assistance listing (CFDA)
- 93.310
Amount
$475,000
Who can apply
Private colleges and universities, Local government agencies, and Public colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director"s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.
Related opportunities
- NIH Director’s Pioneer Award (DP1 Clinical Trial Optional)National Institutes of HealthCloses in 29 daysUp to $700K
- NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)National Institutes of HealthCloses in 30 daysUp to $350K
- NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)National Institutes of HealthCloses in 23 days
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)National Institutes of HealthCloses Apr 2027
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)National Institutes of HealthCloses Apr 2027